Streetbeat News

Revenues

BE

Bloom Energy Corp (NYSE:BE) has extended its Preferred Distributor Agreement with SK ecoplant until 2027, increasing the commitment to 500 MW of Energy Servers. The deal is expected to generate approximately $1.5 billion in product revenue and $3 billion in service revenue over 20 years. SK ecoplant, which has invested $566 million in Bloom and owns about 10% of its shares, will be a preferred distributor for Bloom's SOFC and SOEC products in key markets.

Portfolio Pulse from Shivani Kumaresan

December 22, 2023 | 5:06 pm

TMCI

Six analysts have recently reviewed Treace Medical Concepts (NASDAQ:TMCI), with mixed opinions. The average 12-month price target is now $17.5, down from $21.75, with a high estimate of $28.00 and a low of $11.00. Analysts from firms like Truist Securities, Morgan Stanley, Stifel, and UBS have adjusted their ratings and price targets. Treace Medical Concepts is a commercial-stage orthopaedic medical device company with a patented procedure for bunion correction. The company has shown a revenue growth rate of 23.3% as of September 30, 2023, but has a net margin of -42.99% and an ROE of -12.17%. Its debt-to-equity ratio is 0.51, below the industry average.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 5:00 pm

DIA

IWM

QQQ

SPY

Consumer sentiment in December was revised upwards to 69.7, indicating improved consumer expectations. In contrast, new home sales in November saw a significant decline of 12.2%, the largest since April 2022. Despite mixed economic data, Wall Street traded higher, with speculation of rate cuts following a lower-than-expected PCE inflation report. ETFs like SPY, QQQ, DIA, and IWM all saw increases in early morning trading.

Portfolio Pulse from Piero Cingari

December 22, 2023 | 4:17 pm

RLJ

Analysts have updated their ratings and price targets for RLJ Lodging (NYSE:RLJ), with a mix of bullish, somewhat bullish, and indifferent stances. The average 12-month price target is now $13.12, up from $12.67. Analysts from Truist Securities, Wells Fargo, Oppenheimer, and Barclays have made recent adjustments to their ratings and price targets. RLJ Lodging Trust is a REIT focusing on hotels and has shown positive revenue growth, a high net margin, and strong ROE and ROA, with a prudent debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 4:01 pm

SIBN

SI-BONE Inc (NASDAQ:SIBN), a medical device company, has received mixed analyst ratings over the past three months. Six analysts have provided evaluations, with a shift towards a more bullish sentiment in the last 30 days. The average 12-month price target is $26.00, with a high of $30.00 and a low of $25.00, representing an 11.11% decrease from previous targets. Analysts from Truist Securities, Needham, Cantor Fitzgerald, and Morgan Stanley have adjusted their ratings and price targets, reflecting their views on the company's market conditions and performance. SI-BONE has shown a revenue growth rate of 28.68% as of September 30, 2023, but struggles with a net margin of -29.46% and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 4:00 pm

SYK

Analysts have updated their ratings and price targets for Stryker (NYSE:SYK), with an average 12-month price target of $322.43, up from $300.20. The ratings range from 'Hold' to 'Buy', with recent actions including raises and one lower. Stryker's financials show a solid revenue growth rate of 9.6%, a net margin of 14.1%, but below-average ROE and ROA. The company is a major player in medical equipment and has a strong market presence with a market cap above industry average.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 4:00 pm

TCNNF

California AG Rob Bonta warns of legal risks if the state allows interstate cannabis sales. Pennsylvania advances bills to protect medical cannabis patients from DUI charges without proof of impairment. Ohio police departments maintain zero-tolerance hiring policies despite cannabis legalization. Florida's medical marijuana home cultivation campaign fails due to lack of funds, while Trulieve Cannabis Corp. supports a separate legalization initiative facing legal challenges. Recent polls show strong voter support for marijuana legalization in Florida.

Portfolio Pulse from Jelena Martinovic

December 22, 2023 | 3:44 pm

FL

Foot Locker Inc (NYSE:FL) shares dropped 5.4% to $30.58 due to negative sentiment from Nike's mixed Q2 results and outlook revision. Nike's EPS beat estimates but revenue slightly missed, causing concern in the footwear and athletic apparel sector. Foot Locker, operating in the same industry, is affected by these developments as investors react to potential industry-wide impacts.

Portfolio Pulse from Henry Khederian

December 22, 2023 | 3:27 pm

QSR

YUM

New York is considering Bill A08336, which would require all food services at transportation facilities to be open seven days a week, potentially affecting Chick-fil-A's policy of closing on Sundays. The bill aims to provide reliable food services for travelers and the commercial trucking industry. Chick-fil-A, known for its high revenue despite being closed on Sundays, may face a decision regarding its seven locations at service areas in New York. The company's commitment to Sunday closures is rooted in its founder's religious beliefs, and the family intends to honor this tradition. Chick-fil-A's potential as an IPO candidate could bring additional pressure to reconsider its Sunday closure policy.

Portfolio Pulse from Chris Katje

December 22, 2023 | 3:08 pm

EW

Analysts have provided diverse perspectives on Edwards Lifesciences (NYSE:EW), with 14 ratings in the last three months. The average 12-month price target is now $78.5, down 11.62% from the previous $88.82. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Edwards Lifesciences, known for its medical devices for structural heart disease, has shown a revenue growth of 12.27% and strong financial health with high net margin and ROE. However, its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 3:01 pm